Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
4.010
-0.040 (-0.99%)
At close: Aug 28, 2026, 4:00 PM EDT
4.000
-0.010 (-0.25%)
After-hours: Aug 28, 2026, 7:52 PM EDT
Larimar Therapeutics Market Cap
Larimar Therapeutics has a market cap or net worth of $418.58 million as of August 28, 2026. Its market cap has increased by 25.40% in one year.
Market Cap
418.58M
Enterprise Value
267.26M
1-Year Change
25.40%
Ranking
Category
Stock Price
$4.01
ChartMarket Cap Chart
Since May 29, 2020, Larimar Therapeutics's market cap has increased from $113.38M to $418.58M, an increase of 269.17%. That is a compound annual growth rate of 23.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 418.58M | 28.36% |
| Dec 31, 2025 | 326.10M | 32.06% |
| Dec 31, 2024 | 246.93M | 23.61% |
| Dec 29, 2023 | 199.77M | 11.79% |
| Dec 30, 2022 | 178.70M | -6.49% |
| Dec 31, 2021 | 191.10M | -41.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inhibikase Therapeutics | 438.80M |
| Compass Therapeutics | 432.21M |
| Arcturus Therapeutics Holdings | 431.75M |
| Fennec Pharmaceuticals | 430.27M |
| Atea Pharmaceuticals | 429.90M |
| Benitec Biopharma | 428.40M |
| Rocket Pharmaceuticals | 423.73M |
| Galectin Therapeutics | 405.42M |